These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 16574282

  • 41. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.
    Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garçon N, Krzych U, Marchand M.
    N Engl J Med; 1997 Jan 09; 336(2):86-91. PubMed ID: 8988885
    [Abstract] [Full Text] [Related]

  • 42. Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children.
    Sacarlal J, Aide P, Aponte JJ, Renom M, Leach A, Mandomando I, Lievens M, Bassat Q, Lafuente S, Macete E, Vekemans J, Guinovart C, Sigaúque B, Sillman M, Milman J, Dubois MC, Demoitié MA, Thonnard J, Menéndez C, Ballou WR, Cohen J, Alonso PL.
    J Infect Dis; 2009 Aug 01; 200(3):329-36. PubMed ID: 19569964
    [Abstract] [Full Text] [Related]

  • 43. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B.
    Vaccine; 2007 Mar 01; 25(11):2145-54. PubMed ID: 17254672
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial.
    Aide P, Dobaño C, Sacarlal J, Aponte JJ, Mandomando I, Guinovart C, Bassat Q, Renom M, Puyol L, Macete E, Herreros E, Leach A, Dubois MC, Demoitie MA, Lievens M, Vekemans J, Loucq C, Ballou WR, Cohen J, Alonso PL.
    Vaccine; 2011 Aug 11; 29(35):6059-67. PubMed ID: 21443960
    [Abstract] [Full Text] [Related]

  • 49. Malaria DNA vaccines in Aotus monkeys.
    Gramzinski RA, Maris DC, Doolan D, Charoenvit Y, Obaldia N, Rossan R, Sedegah M, Wang R, Hobart P, Margalith M, Hoffman S.
    Vaccine; 1997 Jun 11; 15(8):913-5. PubMed ID: 9234546
    [Abstract] [Full Text] [Related]

  • 50. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP142 in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage Challenge.
    Obaldia N, Stockelman MG, Otero W, Cockrill JA, Ganeshan H, Abot EN, Zhang J, Limbach K, Charoenvit Y, Doolan DL, Tang DC, Richie TL.
    Clin Vaccine Immunol; 2017 Apr 11; 24(4):. PubMed ID: 28179404
    [Abstract] [Full Text] [Related]

  • 51. [Induction of protective immune responses in rhesus monkey by immunization with recombinant plasmids of polyvalent epitopes of Plasmodium falciparum using cholera toxin B as adjuvant].
    Zhong H, Cao C, Li P, Zhang YH, Shi YL, Ma QJ.
    Yi Chuan Xue Bao; 2000 Apr 11; 27(11):966-71. PubMed ID: 11209690
    [Abstract] [Full Text] [Related]

  • 52. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
    John CC, Moormann AM, Pregibon DC, Sumba PO, McHugh MM, Narum DL, Lanar DE, Schluchter MD, Kazura JW.
    Am J Trop Med Hyg; 2005 Jul 11; 73(1):222-8. PubMed ID: 16014863
    [Abstract] [Full Text] [Related]

  • 53. Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform.
    Langowski MD, Khan FA, Bitzer AA, Genito CJ, Schrader AJ, Martin ML, Soto K, Zou X, Hadiwidjojo S, Beck Z, Matyas GR, Livingstone MC, Batchelor AH, Dutta S.
    Proc Natl Acad Sci U S A; 2020 Feb 11; 117(6):3114-3122. PubMed ID: 31988134
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.
    Wang R, Richie TL, Baraceros MF, Rahardjo N, Gay T, Banania JG, Charoenvit Y, Epstein JE, Luke T, Freilich DA, Norman J, Hoffman SL.
    Infect Immun; 2005 May 11; 73(5):2863-72. PubMed ID: 15845492
    [Abstract] [Full Text] [Related]

  • 56. Induction of antibodies to the Plasmodium falciparum merozoite surface protein-1 (MSP1) by cross-priming with heterologous MSP1s.
    Hui GS, Hashimoto AC, Nikaido CM, Choi J, Chang SP.
    J Immunol; 1994 Aug 01; 153(3):1195-201. PubMed ID: 8027549
    [Abstract] [Full Text] [Related]

  • 57. Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.
    Jiang G, Charoenvit Y, Moreno A, Baraceros MF, Banania G, Richie N, Abot S, Ganeshan H, Fallarme V, Patterson NB, Geall A, Weiss WR, Strobert E, Caro-Aquilar I, Lanar DE, Saul A, Martin LB, Gowda K, Morrissette CR, Kaslow DC, Carucci DJ, Galinski MR, Doolan DL.
    Malar J; 2007 Oct 09; 6():135. PubMed ID: 17925026
    [Abstract] [Full Text] [Related]

  • 58. Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial.
    Macete EV, Sacarlal J, Aponte JJ, Leach A, Navia MM, Milman J, Guinovart C, Mandomando I, López-Púa Y, Lievens M, Owusu-Ofori A, Dubois MC, Cahill CP, Koutsoukos M, Sillman M, Thompson R, Dubovsky F, Ballou WR, Cohen J, Alonso PL.
    Trials; 2007 Mar 26; 8():11. PubMed ID: 17386091
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.
    Imoukhuede EB, Berthoud T, Milligan P, Bojang K, Ismaili J, Keating S, Nwakanma D, Keita S, Njie F, Sowe M, Todryk S, Laidlaw SM, Skinner MA, Lang T, Gilbert S, Greenwood BM, Hill AV.
    Vaccine; 2006 Oct 30; 24(42-43):6526-33. PubMed ID: 16842888
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.